DUBLIN--(BUSINESS WIRE)--The "High Throughput Screening Market by Technology, Application, Product, End User - Global Forecast to 2023" report has been added to ResearchAndMarkets.com's offering.
The HTS market is expected to reach USD 21.69 billion by 2023 from an estimated USD 14.87 billion in 2018, at a CAGR of 7.8%
The initiatives undertaken by pharmaceutical and biotechnology companies, increasing R&D spending, technological developments in HTS, and the availability of government funding and venture capital investments are the factors driving the growth of the HTS market. However, the capital-intensive nature of HTS and complexities in the field of assay development are expected to limit the growth of this market during the forecast period.
On the basis of product & service, the HTS market is segmented into reagents & assay kits, instruments, consumables & accessories, software, and services. The software segment is expected to register the highest CAGR during the forecast period. The increasing automation of high-throughput screening and the availability of robust data management software tools, which enable researchers to develop systemic and process-oriented approaches toward HTS techniques are some of the factors contributing to the growth of this segment.
On the basis of end user, the HTS market is segmented into pharmaceutical and biotechnology companies, academic and government institutes, contract research organizations (CROs), and other end users (hospitals and food, agriculture & environmental industries). The contract research organizations segment is expected to register the highest CAGR during the forecast period owing to the increasing outsourcing of HTS services by many pharmaceutical & biotechnology companies.
North America held the largest share of the global HTS market in 2017. On the other hand, the APAC region is expected to witness the highest CAGR during the forecast period, owing to the increasing R&D spending, growing trend of outsourcing drug discovery services, growing public-private partnerships, and increasing government funding in this region.
Key Topics Covered:
2 Research Methodology
3 Executive Summary
4 Premium Insights
5 Market Overview
6 Industry Insights
7 High-Throughput Screening Market, By Product & Service
8 High-Throughput Screening Market, By Technology
9 High-Throughput Screening Market, By Application
10 High-Throughput Screening Market, By End User
11 High-Throughput Screening Market, By Region
12 Competitive Landscape
13 Company Profiles
- Agilent Technologies, Inc.
- Aurora Biomed
- Axxam S.P.A.
- Bio-Rad Laboratories
- Biotek Instruments
- Corning Incorporated
- Danaher Corporation
- Hamilton Company
- Merck Group
- Perkinelmer, Inc.
- Tecan Group
- Thermo Fisher Scientific Inc.
For more information about this report visit https://www.researchandmarkets.com/research/tsspjq/21_6_billion?w=4